Supply Chain

FedEx will offer customers the opportunity to pickup or drop off packages at almost 8,000 Walgreens locations nationwide.

Heart disease and strokes kill more than 786,000 Americans each year, according to the American Heart Association. With such a massive need for more treatment options, medical device makers are rolling out new cardiac devices and merging with other companies…

While anxiety and depression rates are rising throughout the world, experts say new antidepressants won't hit the market for at least 10 years, reports Reuters.

Drugstore chain CVS disclosed Thursday that it will sell a rival, generic version of Mylan's EpiPen for about one-sixth of the price, according to CNN Money.

Here are seven articles published by Becker's Hospital Review in the past week that offer insight on controversy surrounding the drug industry, the benefits of a career in supply chain and more.

The time has come for drug companies to get serious about making a deal with the government over high drug prices, according to Jake Novak, a senior columnist for CNBC.

 The Food and Drug Administration Wednesday issued a warning over the use of implantable infusion pumps in MRIs.

While the political views of Vermont Sen. Bernie Sanders (I) and President-elect Donald Trump fall on opposite sides of the spectrum, the two men found common ground on one topic: high drug costs.

Richard Gonzalez, the CEO of AbbVie, said the company will not raise drug prices past the single digits in 2017, reports Reuters.

The National Cancer Institute is creating an ambitious new program that will enable scientists to access new drugs and compounds faster for medical research, according to STAT.